Navigation Links
Cholesterol Drug Helps After Angioplasty

According to researchers at the Erasmus University Hospital, a common cholesterol fighting drug, a statin called Lescol or fluvastatin, can reduce the risk of heart complications by up to 20 percent for about 1 million American each year. "This reduction in major heart events -- such as dying of heart disease or suffering another heart attack is quite impressive," said Dr. Patrick Serruys,// professor of interventional cardiology at Erasmus University Hospital, Rotterdam, the Netherlands.

Serruys, the principal investigator of the Lescol Intervention Prevention Study or LIPS, and his colleagues recruited 1,022 patients from 55 institutions in Brazil, Canada and Europe who had undergone angioplasties to open clogged coronary arteries. Patients were eligible if they had their first angioplasty procedure within the previous six months.

In an angioplasty, a balloon-tipped catheter is guided by X-rays to the site of a main artery blockage that keeps blood from the heart. The balloon is inflated and crushes the blockage to the side of the artery wall to allow for greater blood flow. The correction rarely is permanent, however.

"More than a million Americans under angioplasty or similar procedures each year," Serruys said. "Although angioplasties are highly effective in the short-term, 2 out of every 5 patients will suffer a heart attack or will need to have bypass surgery or another angioplasty within five years."

In reporting the results of the LIPS trial at the annual meeting of the American College of Cardiology in Atlanta, Serruys said doctors gave patients a placebo or fluvastatin, a proven cholesterol-lowering medication. After about four years of treatment, Serruys found:

* A 22 percent reduction in death, heart attack or requiring another heart procedure, either open heart bypass surgery or another angioplasty.

* Diabetic patients on fluvastatin experienced a 47 percent reduction in the risk of havi ng a serious cardiac event.

* Patients with atherosclerosis or disease in more than one coronary artery who were taking fluvastatin experienced a 34 percent reduction in serious events.

* Patients who were on fluvastatin saw their low density lipoprotein or LDL -- the so-called bad cholesterol -- fall from about 131 milligrams per deciliter at the start of the trial to 99.1 mg/dL.

Dr. Ira Nash, associate director of the Cardiovascular Institute at Mt. Sinai School of Medicine, New York, said getting LDL cholesterol below 100 is one of the goals of the National Cholesterol Education Program. He also said treatment with cholesterol-lowering statin drugs has been shown to have additional benefits to patients aside from lowering cholesterol -- which is known to help reduce heart attack risk.

"This study may get the attention of the interventional cardiologist," said Dr. Roger Blumnethal, a spokesman for the American Heart Association and director of preventive cardiology at Johns Hopkins Univeristy, Baltimore, Md. "Often the interventionalist leaves the prescribing of statin medication to the primary care doctor and sometimes that addition to the patient's regimen falls through the cracks."

Interventional cardiologists most often perform angioplasties. "I think this and other new studies will go a long way in improving the quality of care of all patients with coronary artery disease," he said. Serruys said the researchers used the drug fluvastatin because it has a proven safety record as patients would be expected to continue taking the drugs for many years, possible for a lifetime. He said other statins, including more potent cholesterol-lowering agents, might not have as solid a safety record.

In LIPS, he said there were no indications of any worrisome liver abnormalities or muscle problems seen with other statin drugs. The study was supported by Novartis Pharmaceuticals, Basel, Switzerland, the manufac turer of Lescol.


'"/>




Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Eating More Often May Help Lower Cholesterol
3. Caution On Use of Cholesterol Drugs
4. High Cholesterol linked to Alzheimer’s diseas
5. Cholesterol lowering drugs increase neuropathy risk
6. Almonds Improve Cholesterol
7. Cholesterol-lowering therapy benefits older people also
8. Cholesterol lowering drugs aid people after heart transplant
9. New Cholesterol gene linked to Alzheimers
10. Children’s Cholesterol Matter
11. Tea Pill Lowers Cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
Breaking Medicine Technology: